Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study

Clinical trial NCT04895202 · TERMINATED

Trial details

NCT number: NCT04895202
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Study type: OBSERVATIONAL

Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity

Start date: 2021-11-19
Primary completion: 2022-12-20
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.